Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 741

1.

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.

Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH; Diabetes Outcome in Veterans Study.

Diabetes Care. 2002 Oct;25(10):1744-8.

PMID:
12351471
[PubMed - indexed for MEDLINE]
2.

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

Diabetes Care. 2003 Jun;26(6):1759-63.

PMID:
12766106
[PubMed - indexed for MEDLINE]
3.
4.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III).

Diabetes Care. 2001 Jun;24(6):979-82.

PMID:
11375356
[PubMed - indexed for MEDLINE]
5.

Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH; Diabetes Outcomes in Veterans Study.

Am J Med Sci. 2004 Jun;327(6):319-23.

PMID:
15201644
[PubMed - indexed for MEDLINE]
6.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
[PubMed - indexed for MEDLINE]
7.

Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.

Hay LC, Wilmshurst EG, Fulcher G.

Diabetes Technol Ther. 2003;5(1):19-26.

PMID:
12725703
[PubMed - indexed for MEDLINE]
8.

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

Diabetes Obes Metab. 2006 Jan;8(1):58-66.

PMID:
16367883
[PubMed - indexed for MEDLINE]
9.
10.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
[PubMed - indexed for MEDLINE]
11.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

Diabetes Care. 2003 May;26(5):1490-6.

PMID:
12716810
[PubMed - indexed for MEDLINE]
12.

A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

Oyer DS, Shepherd MD, Coulter FC, Bhargava A, Brett J, Chu PL, Trippe BS; INITIATEplus Study Group.

Am J Med. 2009 Nov;122(11):1043-9. doi: 10.1016/j.amjmed.2008.12.026.

PMID:
19854333
[PubMed - indexed for MEDLINE]
13.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
[PubMed - indexed for MEDLINE]
14.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
[PubMed - indexed for MEDLINE]
15.

Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.

Murata GH, Shah JH, Wendel CS, Hoffman RM, Adam KD, Bokhari SU, Solvas PA, Duckworth WC.

J Diabetes Complications. 2003 Jul-Aug;17(4):186-91.

PMID:
12810241
[PubMed - indexed for MEDLINE]
16.

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.

Hamann A, Matthaei S, Rosak C, Silvestre L; HOE901/4007 Study Group.

Diabetes Care. 2003 Jun;26(6):1738-44.

PMID:
12766103
[PubMed - indexed for MEDLINE]
17.

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A; INITIATE Study Group.

Diabetes Care. 2005 Feb;28(2):260-5.

PMID:
15677776
[PubMed - indexed for MEDLINE]
18.

Hemoglobin Glycosylation Index is not related with blood glucose.

Merino-Torres JF, Fajardo-Montañana C, Ferrer-García JC, Piñón-Sellés F.

J Diabetes Complications. 2003 Sep-Oct;17(5):249-53.

PMID:
12954152
[PubMed - indexed for MEDLINE]
19.

Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM; Diabetes Outcomes in Veterans Study.

Diabetes Res Clin Pract. 2004 Jul;65(1):61-7.

PMID:
15163479
[PubMed - indexed for MEDLINE]
20.

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

Clin Ther. 2005 May;27(5):554-67.

PMID:
15978304
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk